https://www.amgen.com/newsroom/press-releases/2015/12/pivotal-headtohead-endeavor-study-results-published-in-the-lancet-oncology-demonstrate-superiority-of-kyprolis-carfilzomib-combination-over-velcade-bortezomib-combination
Pivotal Head-To-Head ENDEAVOR Study Results Published in The Lancet Oncology Demonstrate...
the lancet oncologyhead to